Marketing-authorisation holder · United States
Baxter Hlthcare
214 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
214 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 214
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER1.5gm/100ml · Solution | Glycine | United States | Marketed | 1980 |
| ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER10mg base/ml | 20mg base/ml · Injectable | Cefazolin | United States | Not marketed | |
| ANCEF IN PLASTIC CONTAINER10mg base/ml | 20mg base/ml · Injectable | Cefazolin | United States | Not marketed | 1991 |
| ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER10mg base/ml | 20mg base/ml · Injectable | Cefazolin | United States | Not marketed | |
| ATRACURIUM BESYLATE PRESERVATIVE FREE10mg/ml · Injectable | Atracurium | United States | Marketed | 1996 |
| BACTOCILL IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Oxacilina | United States | Marketed | 1989 |
| BIVALIRUDIN IN 0.9% SODIUM CHLORIDE250mg/50ml (5mg/ml) | 500mg/100ml (5mg/ml) · Solution | Bivalirudin | United States | Not marketed | 2017 |
| BRANCHAMIN 4%4% (4gm/100ml) · Injectable | Amino acids | United States | Not marketed | |
| BRANCHAMIN 4% IN PLASTIC CONTAINER4% (4gm/100ml) · Injectable | Amino acids | United States | Not marketed | 1984 |
| BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER100mg/100ml | 200mg/100ml | 400mg/100ml | 800mg/100ml · Injectable | Bretylium tosilate | United States | Not marketed | 1986 |
| BREVIBLOC10mg/ml | 20mg/ml | 250mg/ml · Injectable | Esmolol | United States | Marketed | 1986 |
| BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER2gm/100ml · Injectable | Esmolol | United States | Marketed | 1986 |
| BREVIBLOC IN PLASTIC CONTAINER1gm/100ml · Injectable | Esmolol | United States | Marketed | 1986 |
| BUPIVACAINE HYDROCHLORIDE0.75% · Injectable | Bupivacaine | United States | Marketed | 1987 |
| CARDIOPLEGIC IN PLASTIC CONTAINER17.6mg/100ml; 325.3mg/100ml; 119.3mg/100ml; 643mg/100ml · Solution | Calcium chloride, Magnesium chloride, Potassium chloride, Sodium chloride | United States | Marketed | 2000 |
| CEFAZOLIN IN DEXTROSE1gm base/50ml (eq 20mg base/ml) | 2gm base/100ml (eq 20mg base/ml) | 3gm base/150ml (eq 20mg base/ml) · Solution | Cefazolin | United States | Marketed | 2015 |
| CEFEPIME IN PLASTIC CONTAINER1gm base/50ml (eq 20mg base/ml) | 2gm base/100ml (eq 20mg base/ml) · Injectable | Cefepime | United States | Marketed | 2008 |
| CEFTAZIDIME SODIUM IN PLASTIC CONTAINER10mg base/ml | 20mg base/ml | 40mg base/ml · Injectable | Ceftazidime | United States | Not marketed | 1993 |
| CEFTRIAXONE IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Ceftriaxone | United States | Marketed | 2005 |
| CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Cefalotin | United States | Not marketed | 1984 |
| CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER20mg base/ml | 40mg base/ml · Injectable | Cefalotin | United States | Not marketed | 1984 |
| CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE300mg base/50ml (eq 6mg base/ml) | 600mg base/50ml (eq 12mg base/ml) | 900mg base/50ml (eq 18mg base/ml) · Solution | Clindamycin | United States | Marketed | 2017 |
| CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER12mg base/ml | 18mg base/ml | 6mg base/ml · Injectable | Clindamycin | United States | Marketed | 2012 |
| CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER12mg base/ml | 18mg base/ml | 6mg base/ml | 900mg base/100ml · Injectable | Clindamycin | United States | Not marketed | 1989 |
| CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER2.75%; 10gm/100ml · Injectable | Amino acids, Dextrose | United States | Marketed | 1997 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 214 | 214 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.